News & Pipeline

FDA moves, compounding rules, and what changes for prescribed longevity treatments.

Three Glutathione Recalls in 2026

Three compounding pharmacies recalled injectable glutathione in 2026 over elevated endotoxins. All traced to a contaminated API source.

FDA issued warning letters to five peptide and NAD+ compounders in 2026, including a sermorelin recall. And what it means for patients.